FTSE 100 on Track for Monthly Gain as AstraZeneca Rises

London equities head toward a monthly advance as AstraZeneca shares climb on restructuring news. Investor sentiment improves following a government budget that proved milder on taxes than anticipated.

Xurve View
Insights:
FILE PHOTO: A worker walks near an LSEG (London Stock Exchange Group) branded cube inside the LSEG headquarters in Paternoster Square, London, Britain, September 8, 2026. REUTERS/Toby Melville/File Photo

London's FTSE 100 rose 0.1% to 10,732.58 points during Friday morning trading, heading for its first monthly gain in three months. The blue-chip index added 1.3% over the month, supported by a softer-than-expected budget in the United Kingdom. Meanwhile, the midcap FTSE 250 slipped 0.6% during the session.